https://www.selleckchem.com/products/mitopq.html
Accordingly, treatment with an IL-17A neutralizing antibody diminished SMA remodeling in a model of angiotensin II (Ang II) infusion. Moreover, in vitro studies in VSMCs reported here, provide further evidence of the direct effects of IL-17A on cell growth responses. Our experimental data suggest that IL-17A is a key mediator of vascular remodeling of the small arteries, which might contribute, at least in part, to blood pressure elevation. © 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.Non
إعجاب
علق
شارك
